Previous studies have shown that SL inhibits and stabilizes atherosclerosis plaques through inflammatory reactions and plaque destabilization, which inhibits the expression of the inflammatory mediators, IL-10 and MCP-1, further increasing the expression of the metabolite of inflammatory dispersalin, LXA4 (Li et al., 2011). Here, IL10 is linked to atherosclerosis.